Evidence map›Paper›PMID 29302277›Full record

ArticleThe open AIDS journal2017

Cardiovascular Disease and Cardiovascular Disease Risk in HIV-Positive Populations in the Asian Region.

Rimke Bijker, Jun Yong Choi, Rossana Ditangco, Sasisopin Kiertiburanakul, Man Po Lee, Sarawut Siwamogsatham, Sanjay Pujari, Jeremy Ross, Chi-Yuen Wong, Wing-Wai Wong and 2 more

Open access · diamondAbstract read
In one paragraph

Article in The open AIDS journal, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed
1.6field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 16 citations in OpenAlex.

  1. Article
  2. Review
  3. HIV and Global Cardiovascular Health.Current cardiology reports · 2022
    Review
  4. Review
  5. Review
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

12 authors at 8 institutions in 7 countries.

Rimke BijkerThe Kirby Institute, UNSW, Sydney, NSW 2052, Australia.
Jun Yong ChoiDepartment of Internal Medicine and AIDS Research Institute, Yonsei University College of Medicine, Seoul, Korea.
Rossana DitangcoResearch Institute for Tropical Medicine, Manila, Philippines.
Sasisopin KiertiburanakulFaculty of Medicine Ramathibodi Hospital, Mahidol University, Bangkok, Thailand.
Man Po LeeQueen Elizabeth Hospital, Kowloon, Hong Kong.
Sarawut SiwamogsathamKing Chulalongkorn Memorial Hospital, Bangkok, Thailand.
Sanjay PujariInstitute of Infectious Diseases, Pune, India.
Jeremy RossTREAT Asia, Bangkok, Thailand.
Chi-Yuen WongQueen Elizabeth Hospital, Kowloon, Hong Kong.
Wing-Wai WongTaipei Veterans General Hospital, Taipei, Taiwan.
Evy YunihastutiCipto Mangunkusumo General Hospital, Jakarta, Indonesia.
Matthew LawThe Kirby Institute, UNSW, Sydney, NSW 2052, Australia.
Queen Elizabeth Hospital · CNUNSW Sydney · AUKing Chulalongkorn Memorial Hospital · THRamathibodi Hospital · THResearch Institute for Tropical Medicine · PHRumah Sakit Umum Pusat Nasional Dr. Cipto Mangunkusumo · IDTaipei Veterans General Hospital · TWYonsei University · KR

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionCardiovascular diseases (CVD) are becoming more prevalent in HIV-infected populations as they age largely due to improved treatment outcomes. Assessment of CVD risk and CVD risk factors in HIV-positive populations has focused on high income settings, while there are limited studies evaluating CVD in HIV-positive populations in the Asian region. MATERIALS AND

methodsWe provided an overview of the prevalence and incidence of CVD and its risk factors in adult HIV-positive populations, and of the strategies currently in place for CVD management in the Asian region.

resultsStudies from the Asian region showed that CVD and CVD risk factors, such as dyslipidaemia, elevated blood glucose, obesity and smoking, are highly prevalent in HIV-positive populations. A number of studies suggested that HIV infection and antiretroviral therapy may contribute to increased CVD risk. National HIV treatment guidelines provide some directions regarding CVD risk prevention and management in the HIV-infected population, however, they are limited in number and scope.

conclusionDevelopment and consolidation of guidelines for integrated CVD and HIV care are essential to control the burden of CVD in HIV-positive populations. To inform guidelines, policies and practice in the Asian region, research should focus on exploring appropriate CVD risk screening strategies and estimating current and future CVD mortality and morbidity rates.

Indexed as

AsiaCardiovascular diseaseCardiovascular risk factorsHIV

Identifiers

PMID29302277
PMCPMC5753029
OpenAlexW2739619883

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.